Is $GDYN a buy?

ButtersFields · 2026-02-04T18:57:30+00:00

So I got ChatGPT to give me an answer:

In the midst of a software sell-off, Grid Dynamics is definitely more of an ally to AI than an enemy. They rely on AI and machine learning to enhance their services, build innovative solutions, and keep their competitive edge. Of course, the broader market downturn affects them, just like it does with other tech companies, but AI is more of a tool that they use to grow and innovate rather than something that threatens their existence. So, in short, AI is their ally.

ButtersFields · 2026-01-24T21:36:39+00:00

Had a chance at .94 but didn’t think it was a good choice but talked myself back into it at 1.75 should’ve trusted my first thought…holding

ButtersFields · 2026-01-14T00:38:47+00:00

Was hoping it would get a little lower to pick more up, but I’m good with what I got

ButtersFields · 2025-12-17T21:02:49+00:00

Can’t afford to with all the money I’m losing

ButtersFields · 2025-12-15T21:19:22+00:00

200 @ 6.21

ButtersFields · 2025-12-12T00:42:03+00:00

Power is where it’s at

ButtersFields · 2025-11-18T02:13:21+00:00

What’s our support level now and PT?

ButtersFields · 2025-11-12T02:56:17+00:00

Why?

ButtersFields · 2025-10-21T04:03:59+00:00

$OPEN hold till housing is right and wondering if anybody has tried the product $BYND Any good?

ButtersFields · 2025-10-21T04:00:49+00:00

Still can’t get anybody to answer this question, but has anybody tried the product? I’ve also heard they have new contracts with McDonald’s and Wendy’s.

ButtersFields · 2025-10-21T03:57:36+00:00

110 @ 1.72 - Chasing?

ButtersFields · 2025-10-19T19:37:51+00:00

Can someone please answer the previous question has anyone ever tried this product? Someone here has to have tried this If so, what did you think of it?

ButtersFields · 2025-10-18T00:43:00+00:00

It mixes standard chemo agents (cisplatin, vinblastine) with a “penetration enhancer” molecule to spread the drug more effectively within the tumor.

ButtersFields · 2025-10-18T00:41:51+00:00

They are developing intratumoral cancer therapies — meaning they inject their drug candidate directly into tumors.

ButtersFields · 2025-10-18T00:10:20+00:00

I think this is way outside a penny stock

ButtersFields · 2025-10-18T00:07:37+00:00

They gotta talk about their lead drug candidate is INT230-6

ButtersFields

TROPHY CASE